Neovascular glaucoma treatment in 2012: Role of anti-VEGF agents

被引:3
|
作者
Kodjikian, L. [1 ]
机构
[1] Univ Lyon 1, Serv Ophtalmol, Hop Croix Rousse, F-69004 Lyon, France
来源
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2013年 / 36卷 / 05期
关键词
Neovascular glaucoma; Avastin (R); Bevacizumab; Anti-VEGF; ENDOTHELIAL GROWTH-FACTOR; INTRAVITREAL BEVACIZUMAB; ANGLE NEOVASCULARIZATION; IRIS NEOVASCULARIZATION; RUBEOSIS IRIDIS; AQUEOUS-HUMOR; INJECTION; TRABECULECTOMY; AVASTIN(R); OUTCOMES;
D O I
10.1016/j.jfo.2012.10.012
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Neovascular glaucoma is a serious pathology with a variety of causes. It results from the secretion by hypoxic retinal tissue of growth factors, including vascular endothelial growth factor ( VEGF). Anterior segment involvement begins in the iris, followed by the development of a fibrovascular membrane in the angle, with resultant goniosynechiae. Treatment of the underlying disease consists most often of panretinal photocoagulation. As for the secondary sequelae, current treatment consists of intravitreal injection of anti-VEGF agents. The most utilized agent is bevacizumab or Avastin (R), off-label. Avastin (R) is effective against neovascularization and ocular hypertension, especially in the early stages. It also represents an adjunct to filtering surgery. It appears to be very well tolerated. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:461 / 465
页数:5
相关论文
共 50 条
  • [41] The use of anti-VEGF agents in pregnancy
    Gallagher, Kevin
    Brown, Ffion
    Bilal, Ahmed
    Al-Janabi, Ahmed
    Davies, Nigel
    EYE, 2024, 38 (09) : 1614 - 1615
  • [42] RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST
    Massenzio, Erik
    Xu, David
    Abishek, Robert
    Wibbelsman, Turner D.
    Sheng, Young
    Obeid, Anthony
    Bhatt, Shivani
    Zhang, Qiang
    Sharpe, James
    Park, Carl H.
    Spirn, Marc J.
    Gupta, Omesh P.
    Chiang, Allen
    Shukla, Aakriti
    Shalaby, Wesam S.
    Myers, Jonathan S.
    Hsu, Jason
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2023, 43 (07): : 1150 - 1159
  • [43] The role of blood neutrophil lymphocyte ratio in predicting the initial response to anti-VEGF treatment in neovascular AMD patients
    Gokce, Sabite Emine
    Celik, Aysenur
    Baskan, Ceyda
    IRISH JOURNAL OF MEDICAL SCIENCE, 2024, 193 (01) : 517 - 521
  • [44] The role of blood neutrophil lymphocyte ratio in predicting the initial response to anti-VEGF treatment in neovascular AMD patients
    Sabite Emine Gökce
    Ayşenur Çelik
    Ceyda Başkan
    Irish Journal of Medical Science (1971 -), 2024, 193 : 517 - 521
  • [45] Association between VEGF-A and VEGFR-2 polymorphisms and response to treatment of neovascular AMD with anti-VEGF agents: a meta-analysis
    Wu, Mingxing
    Xiong, Haibo
    Xu, Yan
    Xiong, Xiaojing
    Zou, Hongmi
    Zheng, Minming
    Wang, Xiuqing
    Zhou, Xiyuan
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2017, 101 (07) : 976 - 984
  • [46] Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: Applying clinical trial results to the treatment of everyday patients
    Brown, David M.
    Regillo, Carl D.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 144 (04) : 627 - 637
  • [47] Long-term results of Ahmed glaucoma valve implantation with/without intravitreal anti-VEGF injection in neovascular glaucoma patients
    Sahin, V.
    Ayaz, Y.
    Yucel, I.
    Sen, E. B. T.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2024, 47 (08):
  • [48] The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD
    Faatz, Henrik
    Rothaus, Kai
    Ziegler, Martin
    Book, Marius
    Spital, Georg
    Lange, Clemens
    Lommatzsch, Albrecht
    DIAGNOSTICS, 2022, 12 (11)
  • [49] Prediction of Anti-VEGF Treatment Requirements in Neovascular AMD Using a Machine Learning Approach
    Bogunovic, Hrvoje
    Waldstein, Sebastian M.
    Schlegl, Thomas
    Langs, Georg
    Sadeghipour, Amir
    Liu, Xuhui
    Gerendas, Bianca S.
    Osborne, Aaron
    Schmidt-Erfurth, Ursula
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (07) : 3240 - 3248
  • [50] Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration
    Finger, Robert P.
    Wickremasinghe, Sanjeewa S.
    Baird, Paul N.
    Guymer, Robyn H.
    SURVEY OF OPHTHALMOLOGY, 2014, 59 (01) : 1 - 18